Sipuleucel-T: Autologous Cellular Immunotherapy for Men with Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer
Sipuleucel T is an autologous cellular immunotherapy designed to stimulate an immune response in men diagnosed with asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. Sipuleucel T improves overall survival and provides an additional treatment op...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Ivyspring International Publisher
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119403/ |